Patent · US Active

Peptide vaccines against PCSK9

US10004791B2 · kind B2 · utility

0Cited by

0References

17Claims

0Family size

Assignee

AFFIRIS AG · AT

Inventors

Gergana Galabova · Wien, AT
Guenther Staffler · Wien, AT
Sylvia Brunner · Wien, AT
Gabriele Winsauer · Wien, AT
Andreas Mairhofer · Wien, AT
Claudia Juno · Wien, AT

Key dates

Filing date	Feb 23, 2015
Grant date	Jun 26, 2018
Priority date	—
Expiry date	Feb 23, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/55
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a vaccine capable to induce production of antibodies directed to PCSK9 in vivo.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.